123 results
Page 3 of 7
8-K
EX-99.1
w6ld ibkmffghgbbngm
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
S-8
rnrsk5
17 Mar 21
Registration of securities for employees
4:06pm
S-8
EX-5.1
btjribw4y0whi7 4sn
17 Mar 21
Registration of securities for employees
4:06pm
8-K
EX-10.1
9uw8cm 2go31u
16 Feb 21
Entry into a Material Definitive Agreement
7:10am
424B5
h2q u2fzl
16 Feb 21
Prospectus supplement for primary offering
7:05am
8-K
EX-10.1
evklyjcyj77mxfbb
4 Jan 21
Aravive Announces Board Member Transition to Advisory Role
4:11pm
8-K
EX-10.1
7264yf
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
8-K
EX-10.3
zd88bq
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
8-K
EX-10.1
jkjs9q 20q
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
S-8
gunhncu4dtab821hcs
27 Mar 20
Registration of securities for employees
8:38am
S-8
EX-5.1
jgvdx 4s4165230qyanc
27 Mar 20
Registration of securities for employees
8:38am